针对内动脉瘤的基因疗法:系统性审查
Malia McAvoy1, Buddy Ratner2, Manuel J Ferreira1
1Neurological Surgery, University of Washington, Seattle, Washington, USA.
Journal of neurointerventional surgery
|October 2, 2024
概括
在内动脉瘤中准与癌症相关的基因显示出有希望. 像PDGFRB这样的基因的突变激活了可以用氨酸激酶抑制剂和基因治疗治疗的途径.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 内动脉瘤带来了治疗挑战,有些病例对当前的手术和内血管方法没有反应.
- 与癌症相关的基因的低频率体质变异与内动脉瘤的发展有关.
- 在PDGFRB基因的突变激活ERK和NF-κB信号,提供治疗点.
研究的目的:
- 审查低频率的体质变异在瘤基因和其他基因在动脉瘤发病的作用.
- 探索用于内动脉瘤的基因疗法应用,重点是内血管输送.
主要方法:
- 对体变异和内动脉瘤研究的文献综述.
- 分子通路的分析,包括ERK和NF-κB信号传递.
- 针对性治疗的讨论,如氨酸激酶抑制剂和基因疗法.
主要成果:
- 癌症相关基因的体质变异有助于动脉瘤的形成.
- PDGFRB突变说明了基因变化如何激活关键信号通路.
- 氨酸激酶抑制剂和基因疗法代表了潜在的新型治疗策略.
结论:
- 准特定的分子通路为治疗内动脉瘤提供了一个有希望的途径.
- 基因疗法,特别是内血管在位输送,有可能导致难以治疗的动脉瘤.
- 对体变异和向治疗的进一步研究可能会彻底改变动脉瘤治疗.
相关概念视频
00:59Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
01:26Aneurysm III: Interprofessional Care
3
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
3